All the funding deals in the femtech market
Last updated: 13 July 2026
Download our beautiful pitch about the femtech market
In our femtech market deck, you will find everything you need to understand the market
The femtech market is attracting funding across fertility, maternity, menopause, diagnostics, pelvic health, and women’s clinical care.
We conducted deep research and collected 107 femtech market funding deals announced from 2024 through Q2 2026.
We refresh this femtech market funding page very often as companies announce new investment rounds.
And if you want to better understand this new industry, you should get our beautiful slides covering the femtech market.
Insights
- The 107 femtech market funding deals represent about $1.84 billion in announced capital between 2024 and Q2 2026.
- Femtech market funding reached about $810 million in 2024, helped by large rounds for Flo Health, Maven Clinic, Comanche Biopharma, and Midi Health.
- Fertility remains one of the broadest femtech market segments, covering clinics, insurance, financing, diagnostics, embryo testing, laboratory automation, and reproductive biotechnology.
- Virtual women’s healthcare platforms are raising larger rounds as companies expand from one care area into broader services for women and families.
- Menopause care has become a major femtech market category, with repeated investments in Midi Health, Alloy, Coral, Elektra Health, Omena, and Evela Health.
- Several femtech companies raised more than once during the period, including Gameto, Gesynta Pharma, Midi Health, Pomelo Care, Samphire Neuroscience, Coral, and Ovum.
- Artificial intelligence is increasingly used in the femtech market for breast screening, prenatal imaging, fertility decisions, embryo assessment, and personalized maternal care.
- Medical devices remain important in femtech funding, especially for pelvic-floor conditions, urinary incontinence, childbirth, hormone monitoring, and breast pumping.
- The femtech market is becoming more global, with funded companies across North America, Europe, India, the Middle East, Japan, and Australia.
This chart, included in our femtech market deck, shows annual VC investment in femtech startups
Summary table of the funding deals for the femtech market since 2024
We define the femtech market as technology-enabled products and services that address women’s reproductive and other female-specific health needs.
We include solutions focused on menstrual and cycle health, fertility and contraception, pregnancy and postpartum, menopause, pelvic and sexual health, and clinically oriented tools for conditions that predominantly or uniquely affect women (e.g., breast and gynecological cancers).
We exclude general-purpose health, wellness, fitness, mental health, and consumer apps that are not specifically designed around women’s biology, care pathways, or life stages.
We focused exclusively on pure players, defined as companies with at least 70–80% of their business directly tied to the femtech market.
Our analysis has been done at a global level with a minimum funding threshold of $300k.
You can also read our detailed analysis to understand how funding activity in the femtech market has evolved recently.
If you want a longer-term view, we also have a study of how funding activity in the femtech market has changed over the years.
Also, you should know that we have a dedicated page, updated weekly, with all the latest fundraising deals in the femtech market.
| Name | What they do | Amount in $ | Quarter | Source(s) |
|---|---|---|---|---|
| Intu Diagnostics | Lab-free molecular HPV testing for cervical cancer screening | $1.18M | Q2 2026 | EU-Startups |
| Ovum | AI women’s health platform with personalized insights and longitudinal health data | $2.6M | Q2 2026 | The SaaS News |
| June Health | Women’s healthcare platform offered through employers and partner organizations | $1.75M | Q2 2026 | Femtech Insider |
| Clair Health | Noninvasive wearable for continuous hormone monitoring | $11.6M | Q2 2026 | Femtech Insider |
| Rejoni | Clinical-stage uterine health company developing a healing hydrogel | $25.0M | Q2 2026 | FinSMEs |
| Dioseve | Fertility biotech developing stem-cell-based support for egg maturation | $7.0M | Q2 2026 | PR Newswire |
| Mammogen | RNA blood test for breast cancer detection and biopsy reduction | $30.0M | Q2 2026 | Mammogen |
| HealthFab | Menstrual hygiene company offering reusable and broader period-care products | $2.4M | Q2 2026 | Economic Times |
| Oli / Baymatob | Wearable platform for maternal and fetal monitoring during labor | $6.5M | Q2 2026 | Baymatob |
| Future Fertility | AI tools that assess egg quality for fertility treatment | $4.1M | Q2 2026 | EIN News |
| ScreenPoint Medical | AI software supporting breast cancer detection in mammograms | $14.0M | Q2 2026 | We Will Cure |
| ONTO Health | AI fertility and longevity platform combining diagnostics with clinical automation | $20.0M | Q2 2026 | We Will Cure |
| Wavelet Medical | AI fetal brain monitoring platform for labor and delivery | $7.0M | Q2 2026 | PR Newswire |
| Osteoboost Health | Prescription wearable designed to preserve bone density after menopause | $8.0M | Q2 2026 | Osteoboost |
| Flora Fertility | Insurance platform covering fertility testing, medication, IUI, and IVF | $5.0M | Q2 2026 | PR Newswire |
| SimpliFed | Virtual maternal care for lactation, infant feeding, and obstetric support | $10.8M | Q2 2026 | Femtech Insider |
| Coral | Virtual care for menopause, perimenopause, and hormonal health | $2.9M | Q1 2026 | Femtech Canada |
| myStoria | AI and human care coordination for fertility and hormonal health | $1.625M | Q1 2026 | myStoria |
| Prickly Pear Health | AI women’s brain-health platform focused on the menopause transition | $0.6M | Q1 2026 | PR Newswire |
| Nadia Care | Community-based maternal care platform supporting healthier birth outcomes | $12.0M | Q1 2026 | We Will Cure |
| May Health | Medical device treatment for infertility linked to PCOS | $11.7M | Q1 2026 | BioSpace |
| Midi Health | Virtual care for menopause, perimenopause, and women’s midlife health | $100.0M | Q1 2026 | Business Wire |
| Pinky Promise | AI digital clinic for gynecological, fertility, pregnancy, and menstrual care | $1.0M | Q1 2026 | Femtech Insider |
| Xella Health | Women’s health testing using menstrual fluid, blood, and multi-omics | $3.7M | Q1 2026 | Femtech Insider |
| Feminai | AI wearable for breast cancer screening at home | $6.0M | Q1 2026 | Femtech Insider |
| Pee Safe | Women’s hygiene brand offering menstrual and personal-care products | $32.0M | Q1 2026 | YourStory |
| BrightHeart | AI prenatal ultrasound software for detecting congenital heart conditions | $12.8M | Q1 2026 | Sofinnova Partners |
| Pomelo Care | Virtual healthcare platform for maternity, women, and children | $92.0M | Q1 2026 | Pomelo Care |
| Emm | Smart menstrual cup measuring flow and cycle patterns | $9.0M | Q4 2025 | New Market Pitch |
| Midi Health | Virtual care for menopause, perimenopause, and women’s midlife health | $50.0M | Q4 2025 | Business Insider |
| Visana Health | Virtual women’s clinic for menopause, endometriosis, and gynecological care | $24.0M | Q3 2025 | New Market Pitch |
| BeSound | Breast cancer screening for dense breast tissue and younger women | $6.8M | Q3 2025 | New Market Pitch |
| Evela Health | Menopause care platform serving German-speaking markets | $0.94M | Q3 2025 | New Market Pitch |
| Prenaital | AI prenatal screening for high-risk pregnancy detection | $1.57M | Q3 2025 | New Market Pitch |
| Conceivable Life Sciences | Automated IVF laboratories powered by AI and robotics | $50.0M | Q3 2025 | BioSpace |
| Diana Health | Women’s healthcare practice network working with hospitals | $55.0M | Q3 2025 | PR Newswire |
| Lōvu Health | AI maternal healthcare platform for pregnancy and postpartum support | $8.0M | Q3 2025 | New Market Pitch |
| Mercy BioAnalytics | Liquid biopsy platform for early cancer detection | $59.0M | Q3 2025 | Mercy BioAnalytics |
| Ovum | AI women’s health platform combining personal data and health insights | $1.7M | Q3 2025 | New Market Pitch |
| Gameto | Reproductive biotech developing stem-cell therapies and IVF support | $44.0M | Q3 2025 | PR Newswire |
| Gesynta Pharma | Biopharma developing a non-hormonal treatment for endometriosis | $3.9M | Q3 2025 | Femtech Insider |
| Ovasave | Digital fertility platform offering testing and medical consultations | $1.2M | Q3 2025 | Entrepreneur ME |
| Solence | AI digital therapeutics and lifestyle support for PCOS | $1.87M | Q3 2025 | New Market Pitch |
| Luma Fertility | Technology-enabled fertility care provider in India | $4.0M | Q3 2025 | Femtech Insider |
| Escala Medical | Medical device for repairing pelvic organ prolapse | $4.5M | Q2 2025 | PR Newswire |
| Juniper Genomics | Genome and transcriptome screening platform for IVF embryos | $4.6M | Q2 2025 | Velocity Incubator |
| Joii | AI menstrual monitoring technology for personalized period insights | $2.6M | Q2 2025 | Femtech Insider |
| Samphire Neuroscience | Neuromodulation wearable for menstrual symptoms and pain | $5.0M | Q2 2025 | SOSV |
| ReproNovo | Biopharma developing infertility and uterine-health treatments | $65.0M | Q2 2025 | ReproNovo |
| Overture Life | Automated IVF laboratory technologies designed for greater scale | $20.6M | Q2 2025 | Business Wire |
| Ovo Labs | Fertility treatments designed to improve egg quality and IVF success | $5.0M | Q2 2025 | Max Planck Innovation |
| Trellis Health | Women’s health platform providing personalized data and proactive care | $1.8M | Q2 2025 | Business Wire |
| Cofertility | Egg-freezing and egg-donation platform with shared-cost options | $7.25M | Q2 2025 | Business Wire |
| Wingwomen Technologies | Digital vaginal speculum technology for gynecological examinations | $2.0M | Q1 2025 | Femtech Insider |
| Uresta | Noninvasive device for bladder leaks and stress urinary incontinence | $3.0M | Q1 2025 | Business Wire |
| Sprout Family | Employer benefits for fertility, surrogacy, and adoption | $1.22M | Q1 2025 | Sprout Family |
| Fizimed | Pelvic-floor rehabilitation technology and connected training devices | $4.36M | Q1 2025 | Bpifrance |
| Ataraxis AI | AI precision medicine platform initially focused on breast cancer | $20.4M | Q1 2025 | Ataraxis AI |
| Millie | Technology-enabled clinics for pregnancy and postpartum care | $12.0M | Q1 2025 | Business Wire |
| Amara Therapeutics | Digital therapy for overactive bladder and pelvic-health conditions | $1.96M | Q1 2025 | Amara Therapeutics |
| Coral | Virtual menopause and perimenopause care platform | $2.95M | Q1 2025 | Business Wire |
| Delfina | AI maternal-health platform supporting healthier pregnancy outcomes | $17.0M | Q1 2025 | Delfina |
| Gaia | Fertility insurance and prediction platform for IVF and egg freezing | $14.0M | Q1 2025 | Gaia |
| Allara Health | Virtual specialty care for chronic hormonal conditions | $26.0M | Q1 2025 | PR Newswire |
| Sunfish | Fertility financing and support for IVF, egg freezing, and surrogacy | $10.0M | Q1 2025 | Axios |
| PinkDx | Diagnostics for unclear symptoms linked to gynecological cancers | $5.0M | Q1 2025 | PR Newswire |
| Gesynta Pharma | Biopharma developing a non-hormonal endometriosis treatment | $29.0M | Q1 2025 | Gesynta |
| Twentyeight Health | Digital reproductive and sexual healthcare platform for women | $10.0M | Q1 2025 | PR Newswire |
| Nua Surgical | Surgical retractor system designed for safer Caesarean sections | $7.02M | Q4 2024 | Femtech Insider |
| Persperity Health | Sweat-sensing wearable for real-time hormone monitoring | $1.0M | Q4 2024 | PR Newswire |
| Parallel Fluidics | Microfluidic device manufacturing for IVF and life-science companies | $7.0M | Q4 2024 | PR Newswire |
| India IVF | Technology-enabled fertility clinic platform in India | $1.25M | Q4 2024 | PR Newswire |
| Nua | Menstrual, sanitary, and postpartum consumer products | $4.01M | Q4 2024 | Entrackr |
| Alloy | Menopause telehealth platform providing clinical care and prescriptions | $16.0M | Q4 2024 | Yahoo Finance |
| FertilAI | AI clinical decision support for fertility clinics and IVF | $4.5M | Q4 2024 | FertilAI |
| Pelvital | Intravaginal device for stress urinary incontinence | $2.32M | Q4 2024 | Twin Cities Business |
| Lushi | Fertility concierge and injection support for IVF patients | $5.0M | Q4 2024 | Business Wire |
| Vara AI | AI mammography screening for breast cancer detection | $8.9M | Q4 2024 | GlobeNewswire |
| Maven Clinic | Virtual clinic for fertility, maternity, parenting, menopause, and family health | $125.0M | Q4 2024 | PR Newswire |
| OCON Therapeutics | Intrauterine drug-delivery platform for gynecological conditions | $10.0M | Q3 2024 | Femtech Insider |
| Cercle | AI platform for women’s health data and fertility insights | $6.0M | Q3 2024 | Cercle |
| Laiqa Wellness | Hormonal health platform with cycle tracking and personalized care | $1.78M | Q3 2024 | Femtech Insider |
| Flo Health | App for periods, fertility, pregnancy, and menopause | $200.0M | Q3 2024 | General Atlantic |
| Hyivy Health | Remote pelvic-floor therapy, monitoring, and rehabilitation platform | $2.0M | Q3 2024 | Accesswire |
| Pomelo Care | Virtual maternal and newborn healthcare platform | $46.0M | Q2 2024 | Pomelo Care |
| Axena Health | At-home pelvic-floor device for urinary and fecal incontinence | $9.4M | Q2 2024 | Axena Health |
| Materna Medical | Medical devices for pelvic-floor disorders and safer childbirth | $20.0M | Q2 2024 | Business Wire |
| Elvie | Women’s health devices for breast pumping and pelvic-floor care | $12.19M | Q2 2024 | Femtech Insider |
| Ovom Care | AI-enabled fertility care and IVF clinic platform | $5.18M | Q2 2024 | Femtech Insider |
| Natural Cycles | Digital contraceptive and fertility tracking application | $54.86M | Q2 2024 | Lauxera Capital Partners |
| Gameto | Reproductive biotech developing fertility and ovarian-support technologies | $33.0M | Q2 2024 | PR Newswire |
| May Health | Ovarian rebalancing therapy for infertility linked to PCOS | $25.0M | Q2 2024 | Business Wire |
| Midi Health | Virtual clinic for menopause, perimenopause, and midlife women’s health | $65.0M | Q2 2024 | Midi Health |
| Elektra Health | Virtual menopause care with education and clinical support | $3.3M | Q1 2024 | MedCity News |
| Essence App | Cycle-aware workplace performance and wellbeing application | $0.6M | Q1 2024 | Femtech Insider |
| Samphire Neuroscience | Neuromodulation wearable for PMS symptoms and menstrual pain | $2.29M | Q1 2024 | Femtech Insider |
| Unfabled | Shopping platform for menstrual and reproductive health products | $1.63M | Q1 2024 | Beauhurst |
| Comanche Biopharma | RNA therapy targeting a root cause of preeclampsia | $75.0M | Q1 2024 | Comanche Biopharma |
| Hertility Health | At-home fertility testing with clinical care pathways | $0.99M | Q1 2024 | Beauhurst |
| FamilyWell Health | Maternal mental healthcare embedded within obstetric practices | $4.3M | Q1 2024 | Femtech Insider |
| Omena | Menopause support with symptom tracking and teleconsultations | $0.65M | Q1 2024 | Femtech Insider |
| Oula | Hybrid maternity clinics combining midwifery and obstetric care | $28.0M | Q1 2024 | PR Newswire |
| Sorella | Hybrid women’s healthcare clinic network in France | $5.4M | Q1 2024 | EU-Startups |
| DeepLook Medical | AI image enhancement for breast cancer detection | $1.7M | Q1 2024 | Boston Harbor Angels |
| Chiyo | Nutrition platform for fertility, pregnancy, and postpartum care | $3.0M | Q1 2024 | TechCrunch |
| Ema App | AI assistant for women’s health questions and care navigation | $2.0M | Q1 2024 | EIN Presswire |
| Annabella | Breast-pump technology designed to imitate infant suckling | $8.5M | Q1 2024 | Business Wire |
This market map, featured in our femtech market deck, highlights top companies and startups in the femtech market
Related blog posts
- The latest developments in the femtech market
- The most recent news in the femtech market
- What is the true size of the femtech market?
- The latest funding news in the femtech market
- What are the key fundraising trends in the femtech market?
